STAAR Surgical Company (STAA)Healthcare | Medical Instruments & Supplies | Lake Forest, United States | NasdaqGM
22.11 USD
-0.28
(-1.251%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 22.11 |
Hot Take ↕ | Aug. 22, 2026, 1:12 a.m. EDT
The investment case here is fractured by a stark divergence between the company's operational recovery and the market's lingering trauma. Fundamentally, the business is showing signs of life with revenue growth exceeding 100% and gross margins expanding to healthy levels above 75%. The balance sheet is pristine, with negligible debt and massive cash reserves, which supports a 'solid long-term buy' thesis if the market accepts the new reality. However, the price action tells a different story; the stock has endured four consecutive years of declines, dragging the long-term rating down despite the positive earnings trajectory. This multi-year decline suggests the market views the previous volatility as a permanent structural flaw rather than a cyclical dip. On the short end, the technicals are mixed; while the stock recently bounced off lows, the statistical forecast offers no guidance, and options flow shows hedging activity that outweighs pure bullish speculation. Until the price decisively breaks above the 50-day moving average to confirm a trend reversal, the risk remains elevated. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.089326 |
| MSTL | 0.096951 |
| AutoTheta | 0.288756 |
| AutoARIMA | 0.347011 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 56.06 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.077 |
| Excess Kurtosis | -0.99 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.836 |
| Revenue per Share | 6.804 |
| Market Cap | 1,108,683,520 |
| Trailing P/E | 276.38 |
| Forward P/E | 21.60 |
| Beta | 1.23 |
| Profit Margins | 1.13% |
| Website | https://www.staar.com |
As of Aug. 22, 2026, 1:12 a.m. EDT: Speculators are positioning defensively with heavy put volume at strikes significantly below the current price (12.5 and 17.5), indicating a fear of a deeper decline. However, there is also notable call interest at distant strikes (30.0 and 40.0), suggesting a belief in a potential rebound to test previous highs. The implied volatility is elevated relative to the low trading volume, reflecting uncertainty rather than a clear directional consensus.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.20295602 |
| Address1 | 25,510 Commercentre Drive |
| All Time High | 163.08 |
| All Time Low | 0.79 |
| Ask | 29.05 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 2.7 - Hold |
| Average Daily Volume10 Day | 752,380 |
| Average Daily Volume3 Month | 834,379 |
| Average Volume | 834,379 |
| Average Volume10Days | 752,380 |
| Beta | 1.231 |
| Bid | 16.92 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 7.29 |
| City | Lake Forest |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 22.11 |
| Current Ratio | 4.665 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 22.45 |
| Day Low | 21.89 |
| Debt To Equity | 9.836 |
| Earnings Call Timestamp End | 1,786,570,200 |
| Earnings Call Timestamp Start | 1,786,570,200 |
| Earnings Timestamp | 1,786,564,800 |
| Earnings Timestamp End | 1,794,427,200 |
| Earnings Timestamp Start | 1,794,427,200 |
| Ebitda | 49,764,000 |
| Ebitda Margins | 0.14654 |
| Enterprise To Ebitda | 19.354 |
| Enterprise To Revenue | 2.836 |
| Enterprise Value | 963,135,488 |
| Eps Current Year | 0.7625 |
| Eps Forward | 1.02375 |
| Eps Trailing Twelve Months | 0.08 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 626 359 8402 |
| Fifty Day Average | 25.6822 |
| Fifty Day Average Change | -3.5721989 |
| Fifty Day Average Change Percent | -0.1390924 |
| Fifty Two Week Change Percent | -20.295603 |
| Fifty Two Week High | 35.87 |
| Fifty Two Week High Change | -13.759998 |
| Fifty Two Week High Change Percent | -0.38360745 |
| Fifty Two Week Low | 15.59 |
| Fifty Two Week Low Change | 6.5200005 |
| Fifty Two Week Low Change Percent | 0.41821682 |
| Fifty Two Week Range | 15.59 - 35.87 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 698,941,800,000 |
| Float Shares | 26,125,016 |
| Forward Eps | 1.02375 |
| Forward P E | 21.59707 |
| Free Cashflow | 15,348,500 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 921 |
| Fullday Change | -0.279999 |
| Fullday Change Percent | -1.25055 |
| Fullday Price | 22.11 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.76622003 |
| Gross Profits | 260,202,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00854 |
| Held Percent Institutions | 1.11614 |
| Implied Shares Outstanding | 50,143,984 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ir Website | http://www.staar.com/html/investor-info.html |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,312,000 |
| Last Split Date | 706,147,200 |
| Last Split Factor | 1:2 |
| Long Business Summary | STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. |
| Long Name | STAAR Surgical Company |
| Market | us_market |
| Market Cap | 1,108,683,520 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_305046 |
| Most Recent Quarter | 1,783,036,800 |
| Net Income To Common | 3,839,000 |
| Next Fiscal Year End | 1,798,848,000 |
| Non Diluted Market Cap | 1,122,723,801 |
| Number Of Analyst Opinions | 10 |
| Open | 22.33 |
| Operating Cashflow | -3,252,000 |
| Operating Margins | 0.10885999 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.76 |
| Phone | 626 303 7902 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 22.11 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 22.39 |
| Price Eps Current Year | 28.996723 |
| Price Hint | 2 |
| Price To Book | 3.032922 |
| Price To Sales Trailing12 Months | 3.2647707 |
| Profit Margins | 0.0113 |
| Quick Ratio | 3.863 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.66667 |
| Region | US |
| Regular Market Change | -0.279999 |
| Regular Market Change Percent | -1.25055 |
| Regular Market Day High | 22.45 |
| Regular Market Day Low | 21.89 |
| Regular Market Day Range | 21.89 - 22.45 |
| Regular Market Open | 22.33 |
| Regular Market Previous Close | 22.39 |
| Regular Market Price | 22.11 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 442,976 |
| Return On Assets | 0.05649 |
| Return On Equity | 0.0109399995 |
| Revenue Growth | 1.11 |
| Revenue Per Share | 6.804 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 50,143,984 |
| Shares Percent Shares Out | 0.0876 |
| Shares Short | 4,390,186 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 5,094,402 |
| Short Name | STAAR Surgical Company |
| Short Percent Of Float | 0.1826 |
| Short Ratio | 4.02 |
| Source Interval | 15 |
| State | CA |
| Symbol | STAA |
| Target High Price | 37.0 |
| Target Low Price | 19.0 |
| Target Mean Price | 27.9 |
| Target Median Price | 27.5 |
| Total Cash | 181,488,992 |
| Total Cash Per Share | 3.619 |
| Total Debt | 35,941,000 |
| Total Revenue | 339,590,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.08 |
| Trailing P E | 276.375 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 24.11715 |
| Two Hundred Day Average Change | -2.0071487 |
| Two Hundred Day Average Change Percent | -0.08322496 |
| Type Disp | Equity |
| Volume | 442,976 |
| Website | https://www.staar.com |
| Zip | 92,630 |